[Clinical experiences with psilocybin Sandoz (CY39 Sandoz)].
No abstract is available for this record.
Bibliographic context
- Journal
- Unknown
- Date
- 1960-12-31
- Source
- Europe PMC
- DOI
- Unavailable
- PubMed
- 13910755
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.
Related papers
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)Journal of Anesthesiology and Pain Therapy · 2022-10-02Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-02S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in Psychiatry and Psychotherapy · 2024-12-31Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.Biomedicine & Pharmacotherapy · 2022-08-29A new behavior change program using psilocybin.Psychotherapy · 1964-12-31